Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Pain. 2013 Oct 27;15(2):136–148. doi: 10.1016/j.jpain.2013.10.005

Table 3.

Immediate changes in pain sensitivity

Mechanical Pain Sensitivity PSIS Mechanical Pain Sensitivity Dorsum of the Foot Suprathreshold Heat Response Aftersensation

SMT Pre 19.12 (20.96) 22.14 (20.16) 36.57 (22.81) 13.75 (12.46)
Post 18.56 (23.18) 26.10 (26.77) 29.54 (23.64)*& 6.00 (4.57)

Placebo Pre 26.48 (30.02) 23.22 (25.76) 31.04 (22.01) 12.67 (9.25)
Post 23.64 (28.93) 24.16 (27.00) 34.07 (24.37) 11.67 (13.69)

Placebo+ Pre 18.81 (23.82) 15.24 (15.28) 27.00 (22.19) 6.75 (3.58)
Post 11.78 (16.67) 20.39 (29.14) 25.78 (22.78) 3.63 (2.39)

No Treatment Pre 21.68 (26.46) 29.27 (27.92) 26.61 (24.92) 9.62 (11.09)
Post 21.23 (27.20) 28.19 (26.53) 29.54 (23.64) 11.69 (13.79)

Total Sample Pre 21.55 (25.39) 22.60 (23.16) 30.33 (23.07) 10.61 (9.85)
Post 18.89 (24.60) 24.78 (27.12) 29.45 (22.90) 8.79 (10.94)

All data are reported as mean (standard deviation). Placebo+= placebo SMT provided with instructional set to enhance expectation. Suprathreshold heat response expressed as the rating of the 5th pulse in the suprathreshold heat response protocol using a numeric rating scale with 0= no pain to 100= worst pain imaginable. Aftersensation= pain report through numeric rating scale with 0= no pain to 100= worst pain imaginable provided 15 seconds following the 10th pulse in the suprathreshold heat response protocol. 38/100 (34.5%) of participants reported persistent pain 15 seconds following the 10th pulse in the suprathreshold heat response protocol. Aftersensation information is provided only for the participants who reported persistent pain.

*

significant between group differences (p≤ 0.05)

&

significant within group differences (p≤ 0.05).